Skip Navigation U.S. Department of Health and Human Services
Agency for Healthcare Research Quality
Archive print banner
Hospital Surge Model Version 1.3: Description

Public Health Emergency Preparedness

This resource was part of AHRQ's Public Health Emergency Preparedness (PHEP) program, which was discontinued on June 30, 2011, in a realignment of Federal efforts.

This information is for reference purposes only. It was current when produced and may now be outdated. Archive material is no longer maintained, and some links may not work. Persons with disabilities having difficulty accessing this information should contact us at: Let us know the nature of the problem, the Web address of what you want, and your contact information.

Please go to for current information.

Chapter 11: Yersinia Pestis (Plague) (continued)

11.7 References

1. Boulanger LL, Ettestad P, Fogarty JD, Dennis DT, Romig D, Mertz G. Gentamicin and tetracyclines for the treatment of human plague: review of 75 cases in New Mexico, 1985-1999. Clin Infect Dis 2004;38:663-9.

2. Butler T, Levin J, Linh NN, Chau DM, Adickman M, Arnold K. Yersinia pestis infection in Vietnam, II: quantitative blood cultures and detection of endotoxin in the cerebrospinal fluid of patients with meningitis. J Infect Dis 1976;133(5):493-9.

3. Cavanaugh DC, Dangerfield HG, Hunter DH, et al. Some observations on the current plague outbreak in the Republic of Vietnam. Am J Public Health Nations Health 1968;58(4):742-52.

4. Centers for Disease Control and Prevention. Fatal human plague—Arizona and Colorado, 1996. MMWR Morb Mortal Wkly Rep 1997;46(27):617-20.

5. Centers for Disease Control and Prevention. Human plague—United States, 1993-1994. MMWR Morb Mortal Wkly Rep 1994;43(13):242-6.

6. Centers for Disease Control and Prevention. Imported plague—New York City, 2002. MMWR Morb Mortal Wkly Rep 2003;52(31):725-8.

7. Centers for Disease Control. Plague pneumonia—California. MMWR Morb Mortal Wkly Rep 1984;33(34):481-3.

8. Chernin E. Richard Pearson Strong and the Manchurian epidemic of pneumonic plague, 1910-1911. J Hist Med Allied Sci 1989;44(3):296-319.

9. Cohen RJ, Stockard JL. Pneumonic plague in an untreated plague-vaccinated individual. JAMA 1967;202(4):365-6.

10. Cramer C, Christensen B. Pneumonic plague in a 15-year-old Utah girl. J Emerg Nurs 1995;21(6):491-3.

11. Crook LD, Tempest B. Plague: a clinical review of 27 cases. Arch Intern Med 1992;152(6):1253-6.

12. Cunha BA. Anthrax, tularemia, plague, Ebola or smallpox as agents of bioterrorism: recognition in the emergency room. Clin Microbiol Infect 2002;8(8):489-503.

13. Dennis DT, Chow CC. Plague. Pediatr Infect Dis J 2004;23(1):69-71.

14. Franz DR, Jahrling PB, McClain DJ, et al. Clinical recognition and management of patients exposed to biological warfare agents. Clin Lab Med 2001;21(3):435-73.

15. Fritz CL, Dennis DT, Tipple MA, Campbell GL, McCance CR, Gubler DJ. Surveillance for pneumonic plague in the United States during an international emergency: a model for control of imported emerging diseases. Emerg Infect Dis 1996;2(1):30-6.

16. From the Centers for Disease Control: pneumonic plague—Arizona, 1992. JAMA 1992;268(16):2146-7.

17. Gabastou JM, Proano J, Vimos A, et al. An outbreak of plague including cases with probable pneumonic infection, Ecuador, 1998. Trans R Soc Trop Med Hyg 2000;94(4):387-91.

18. Gage KL, Dennis DT, Orloski KA, et al. Cases of cat-associated human plague in the Western US, 1977-1998. Clin Infect Dis 2000;30(6):893-900.

19. Galimand M, Guiyoule A, Gerbaud G, et al. Multidrug resistance in Yersinia pestis mediated by a transferable plasmid. N Engl J Med 1997;337(10):677-80.

20. Gani R, Leach S. Epidemiologic determinants for modeling pneumonic plague outbreaks. Emerg Infect Dis 2004;10(4):608-14.

21. Gaval SR, Shrikhande SN, Makhija SK, Tankhiwale NS, Pathak AA, Saoji AM. Study of suspected plague cases for isolation and identification of Yersinia pestis. Indian J Med Sci 1996;50(12):335-8.

22. Heaton JA, Murphy AM, Allan S, Pietz H. Legal preparedness for public health emergencies: TOPOFF 2 and other lessons. J Law Med Ethics 2003;31(4 Suppl):43-4.

23. Inglesby TV, Dennis DT, Henderson DA, et al. Plague as a biological weapon: medical and public health management. Working Group on Civilian Biodefense. JAMA 2000;283(17):2281-90.

24. Inglesby TV, Grossman R, O'Toole T. A plague on your city: observations from TOPOFF. Clin Infect Dis 2001;32(3):436-45.

25. Inglesby TV, Henderson DA, O'Toole T, Dennis DT. Safety precautions to limit exposure from plague-infected patients. JAMA 2000;284(13):1648-9.

26. Joshi K, Thakur JS, Kumar R, Singh AJ, Ray P, Jain S, Varma S. Epidemiological features of pneumonic plague outbreak in Himachal Pradesh, India. Trans R Soc Trop Med Hyg 2009 May;103(5):455-60.

27. Josko D. Yersinia pestis: still a plague in the 21st century. Clin Lab Sci 2004;17(1):25-9.

28. Kellogg W. An epidemic of pneumonic plague. Am J Pub Health 1920;10:599-605.

29. Madan TN. The plague in India, 1994. Soc Sci Med 1995;40(9):1167-8.

30. Mann JM, Shandler L, Cushing AH. Pediatric plague. Pediatrics 1982;69(6):762-7.

31. Marshall JD Jr, Bartelloni PJ, Cavanaugh DC, Kadull PJ, Meyer KF. Plague immunization, II: relation of adverse clinical reactions to multiple immunizations with killed vaccine. J Infect Dis 1974;129(Suppl):S19-S25.

32. Mavalankar DV. Indian "plague" epidemic: unanswered questions and key lessons. J R Soc Med 1995;88(10):547-51.

33. McClean KL. An outbreak of plague in northwestern province, Zambia. Clin Infect Dis 1995;21(3):650-2.

34. McIntosh BA, Hinds P, Giordano LM. The role of EMS systems in public health emergencies. Prehospital Disaster Med 1997;12(1):30-5.

35. Meyer KF. Effectiveness of live or killed plague vaccines in man. Bull World Health Organ 1970;42(5):653-66.

36. Mudur G. India's pneumonic plague outbreak continues to baffle. BMJ 1995;311(7007):706.

37. Murdock J. Pneumonic plague in Ecuador during 1939. Public Health Rep 1940;55:2172-78.

38. Perry RD, Fetherston JD. Yersinia pestis—etiologic agent of plague. Clin Microbiol Rev 1997;10(1):35-66.

39. Persell DJ, Arangie P, Young C, et al. Preparing for bioterrorism: category A agents. Nurse Pract 2001;26(12):12-5, 9-24, 7; quiz 8-9.

40. Plague. In: Benenson AS, ed. Control of Communicable Disease in Man. 16th ed. Washington, DC: American Public Health Association; 1995: 353-8.

41. Prevention of plague: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 1996;45(RR-14):1-15.

42. Ramalingaswami V. Psychosocial effects of the 1994 plague outbreak in Surat, India. Mil Med 2001;166(12 Suppl):29-30.

43. Ratsitorahina M, Chanteau S, Rahalison L, Ratsifasoamanana L, Boisier P. Epidemiological and diagnostic aspects of the outbreak of pneumonic plague in Madagascar. Lancet 2000;355(9198):111-3.

44. Russell P, Eley SM, Green M, et al. Efficacy of doxycycline and ciprofloxacin against experimental Yersinia pestis infection. J Antimicrob Chemother 1998;41(2):301-5.

45. Russell P, Eley SM, Hibbs SE, Manchee RJ, Stagg AJ, Titball RW. A comparison of plague vaccine, USP and EV76 vaccine induced protection against Yersinia pestis in a murine model. Vaccine 1995;13(16):1551-6.

46. Shih CL, Shih FY. Plague in bioterrorism. Ann Disaster Med 2002;1(Suppl 1):S26-S35.

47. Titball RW, Leary SE. Plague. Br Med Bull 1998;54(3):625-33.

48. Titball RW, Williamson ED. Vaccination against bubonic and pneumonic plague. Vaccine 2001;19(30):4175-84.

49. Welty TK, Grabman J, Kompare E, et al. Nineteen cases of plague in Arizona: a spectrum including ecthyma gangrenosum due to plague and plague in pregnancy. West J Med 1985;142(5):641-6.

50. Weniger BG, Warren AJ, Forseth V, et al. Human bubonic plague transmitted by a domestic cat scratch. JAMA 1984;251(7):927-8.

51. Werner SB, Weidmer CE, Nelson BC, Nygaard GS, Goethals RM, Poland JD. Primary plague pneumonia contracted from a domestic cat at South Lake Tahoe, Calif. JAMA 1984;251(7):929-31.

52. White ME, Gordon D, Poland JD, Barnes AM. Recommendations for the control of Yersinia pestis infections: recommendations from the CDC. Infect Control 1980;1(5):324-9.

Return to Contents
Proceed to Next Section


The information on this page is archived and provided for reference purposes only.


AHRQ Advancing Excellence in Health Care